Nevro Corp reports results for the quarter ended September 30 - Earnings Summary

Nevro

12/11/2024 03:42

* Nevro Corp  NVRO.N  reported a quarterly adjusted loss
of 41
cents​​ per share for the quarter ended September 30, higher
than the same quarter last year, when the company reported EPS
of -65 cents.  The mean expectation of fifteen analysts for the
quarter was for a loss of 81 cents per share. Wall Street
expected results to range from -98 cents to -62 cents per share.
    * Revenue fell 6.7% to $96.91 million from a year ago;
analysts
expected $93.07 million. 
    * Nevro Corp's reported EPS for the quarter was a loss of 41
cents​.
    * The company reported a quarterly loss of $15.34 million.
    * Nevro Corp shares had fallen by 9.1% this quarter and
lost 76.4%
so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 2.6%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 12
"hold" and 4 "sell" or "strong sell." 
    * The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "hold"

Wall Street's median 12-month price target for Nevro Corp is
7.00 
This summary was machine generated from LSEG data November 12 at
03:42 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.81          -0.41          Beat
 Jun. 30 2024      -0.68          -0.53          Beat
 Jan. 1 0001       -1.05          -0.58          Beat
 Dec. 31 2023      -0.49          -0.25          Beat